Published in Med Oral Patol Oral Cir Bucal on September 01, 2015
Beta-catenin in disease. J Oral Maxillofac Pathol (2016) 0.75
Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance. Eur J Oral Sci (2017) 0.75
The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol (2004) 24.63
Wnt signalling in stem cells and cancer. Nature (2005) 19.26
Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell (1982) 9.29
Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A (1995) 7.31
Oral cancer and precancerous lesions. CA Cancer J Clin (2002) 4.76
Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med (2007) 4.72
Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol (1997) 4.29
Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem (1997) 4.28
The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet (2000) 3.91
Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med (2008) 2.82
Signal transduction by the Wnt family of ligands. Biochem J (1998) 2.66
Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets (2004) 1.72
Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst (1990) 1.61
Wnt signaling and human diseases: what are the therapeutic implications? Lab Invest (2007) 1.51
Circadian variation in the expression of cell-cycle proteins in human oral epithelium. Am J Pathol (1999) 1.43
Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. J Oral Pathol Med (1999) 1.38
Diseases of Wnt signaling. Rev Endocr Metab Disord (2006) 1.36
The Wnt/beta-catenin signaling pathway as a target in drug discovery. J Pharmacol Sci (2007) 1.34
Oral erythroplakia--a review. Oral Oncol (2005) 1.18
p16 Promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia. Cancer Epidemiol Biomarkers Prev (2008) 1.13
Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression. J Pathol (2002) 1.12
Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol (1998) 1.10
Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med (1998) 1.01
Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia. Mol Cancer (2007) 0.96
Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx. J Laryngol Otol (1996) 0.94
Clinical significance of head and neck squamous cell cancer biomarkers. Oral Oncol (2013) 0.92
Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas. Anal Cell Pathol (1994) 0.92
Molecular alterations in oral carcinogenesis: significant risk predictors in malignant transformation and tumor progression. Int J Biol Markers (2007) 0.91
Analysis of Ki-67 expression in oral squamous cell carcinoma: why Ki-67 is not a prognostic indicator. Oral Oncol (2010) 0.90
Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth. J Pathol (1997) 0.86
beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck. Clin Cancer Res (2005) 0.86
Dysplasia of oral mucosa: a unified approach to proper evaluation. Mod Pathol (1991) 0.86
Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med (2002) 0.86
Aberrant β-catenin expression in the histologic differentiation of oral squamous cell carcinoma and verrucous carcinoma: an immunohistochemical study. J Oral Sci (2010) 0.82
[WNT-β-catenin signaling pathway and its relationship with cancer]. Cir Cir (2013) 0.81
Ki-67 quantitative evaluation as a marker of cervical intraepithelial neoplasia and human papillomavirus infection. Int J Gynecol Cancer (2010) 0.81
Subcellular localization of beta-catenin in malignant cell lines and squamous cell carcinomas of the oral cavity. J Oral Pathol Med (2002) 0.81
Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma. Pathol Oncol Res (2005) 0.78
beta- and gamma-catenin expression in oral dysplasia. Oral Oncol (2008) 0.78
Expression of beta-catenin in rat oral epithelial dysplasia induced by 4-nitroquinoline 1-oxide. Oral Oncol (2002) 0.78
Epithelial cell kinetics in oral leukoplakia. J Oral Pathol Med (1995) 0.77
Defining a new candidate gene for amelogenesis imperfecta: from molecular genetics to biochemistry. Biochem Genet (2010) 0.93
Antidepressant-like effect of a Ginkgo biloba extract (EGb761) in the mouse forced swimming test: role of oxidative stress. Neurochem Int (2011) 0.89
Ginkgo biloba Extract 761: A Review of Basic Studies and Potential Clinical Use in Psychiatric Disorders. CNS Neurol Disord Drug Targets (2015) 0.84
Effect of a phytopharmaceutical medicine, Ginko biloba extract 761, in an animal model of Parkinson's disease: therapeutic perspectives. Nutrition (2012) 0.83
EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity. Neurochem Res (2004) 0.81
Oral metastasis of renal cell carcinoma, presentation of a case. Med Oral Patol Oral Cir Bucal (2008) 0.76
Reduction of zinc-positive terminal fields in striatum of mouse after 1-methyl-4-phenylpyridinium neurotoxicity. Neurotoxicology (2005) 0.76
Viability and functional capacity after thawing of hematopoietic progenitor cells cryopreserved at a cord blood stem cell bank in Colombia. Int J Gynaecol Obstet (2010) 0.75